Showing results (1471-1480 of 3,637) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|December 1, 2014
Do pathological parameters differ with regard to breast density and mode of detection in breast cancer? The Malmö Diet and Cancer StudyHanna Sartor, Signe Borgquist, Linda Hartman, et al.Breast (Edinburgh, Scotland)|December 4, 2014
Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysisEsther Molina-Montes, Beatriz Pérez-Nevot, Marina Pollán, et al.Breast (Edinburgh, Scotland)|December 4, 2014
Lymphedema care for the breast cancer patient: an integrative approachGail Elliott Patricolo, Karen Armstrong, Justin Riutta, et al.Breast (Edinburgh, Scotland)|December 4, 2014
Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy with carboplatin and paclitaxel with or without trastuzumabArvind M Shinde, Jing Zhai, Kim Wai Yu, et al.Breast (Edinburgh, Scotland)|January 14, 2020
Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancerXiuwen Guan, Binliang Liu, Yunyun Niu, et al.Breast (Edinburgh, Scotland)|January 14, 2020
Winter is over: The use of Artificial Intelligence to individualise radiation therapy for breast cancerPhilip M P Poortmans, Silvia Takanen, Gustavo Nader Marta, et al.Breast (Edinburgh, Scotland)|November 7, 2020
Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trialMichael J Hale, Anthony Howell, Mitch Dowsett, et al.Breast (Edinburgh, Scotland)|September 1, 2020
Epidemiology of male breast cancerSanthi Konduri, Maharaj Singh, George Bobustuc, et al.Breast (Edinburgh, Scotland)|November 14, 2020
First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA studyAnne-Claire Hardy-Bessard, Fabien Brocard, Florian Clatot, et al.Breast (Edinburgh, Scotland)|February 18, 2020
Machine-learned identification of psychological subgroups with relation to pain interference in patients after breast cancer treatmentsReetta Sipilä, Eija Kalso, Jörn LötschPageof 364